10 articles for CY Kim
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators).
Wyeth Research
1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.
Wyeth Research
Improvement of physiochemical properties of the tetrahydroazepinoindole series of farnesoid X receptor (FXR) agonists: beneficial modulation of lipids in primates.
Wyeth Research
Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR).
Wyeth Research
Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.
Wyeth Research
Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.
Wyeth Research
Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease.
Korea University
Cyclocurcumin, an Antivasoconstrictive Constituent of Curcuma longa (Turmeric).
Seoul National University
Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV.
University of Pennsylvania
